Researcher
Peter Vandenberghe
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Responsible
From1 Jan 2008 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → Today
Projects
1 - 10 of 19
- Establishing an evidence ecosystem for blood donation deferral criteria in men who have sex with menFrom9 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Map, Join and Drive European Activities for Advanced Therapy Medicinal Product Development and Implementation for Patient and Society BenefitFrom1 Jan 2024 → TodayFunding: Horizon Europe - Health
- PhD project to identify the immune signature after CAR T-cells treatment.From5 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- In-depth investigation of patient immune signature after CD19 CAR T-cell therapyFrom1 Mar 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Integrated PK/PM Model-based Medication Dosing Assist App(lication) in KlinischWerkStation (KWS). Validation Studies of Tacrolimus in (Solid) Organ TransplantationFrom1 Jan 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
- Mechanisms and Diagnosis of Mast Cell and Basophil Activation in Rare Hypersensitivity DisordersFrom1 Nov 2020 → TodayFunding: BOF - doctoral mandates
- Tracking Multiple Myeloma by low-pass sequencing of circulating cell free DNAFrom1 Mar 2019 → 1 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Circulating cell-free DNA as an alternative gateway to the genetic features of multiple myeloma and as a surrogate marker for disease burden in multiple myeloma.From1 Mar 2019 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2017 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
Publications
221 - 229 of 229
- Methylation studies of the DLK1-GTL2 imprinted domain in B-cell malignancies with IGH-involving del(14)(2008)
Authors: Beata Katrincsakova, Carole Charlier, Helena Urbankova, Lucienne Michaux, Marie Jarosova, Peter Vandenberghe, Michel George, Iwona Krajewska
Pages: 260 - 261 - Array-CGH mapping of an overrepresented 7q region in gamma/delta hepatosplenic T-cell lymphoma(2008)
Authors: Helena Urbankova, Shashirekha Shetty, Birgitte Poland, Laszlo Krenacs, Johan Billiet, Marie Jarosova, Peter Vandenberghe, Iwona Krajewska
Pages: 277 - 277 - MicroRNA signatures in Genetic Subtypes of T-Cell Acute Lymphoblastic Leukemia(2008)
Authors: P Van Vlierberghe, B Poppe, N Van Roy, T Taghon, J Plum, B Cauwelier, D Selleslag, P Heimann, Peter Vandenberghe, N Dastugue, et al.
Pages: 1153 - 1154 - CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
Authors: Johan Maertens, Peter Vandenberghe
Pages: 1241 - 1243 - t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia
Authors: Koen Debackere, Lucienne Michaux, Peter Vandenberghe
Pages: 665 - 668 - Een 67-jarige man met een gestegen hemoglobine en ferritine
Authors: Wouter Meersseman, Peter Vandenberghe
Pages: 220 - 222 - Hyperplasia of Interstitial Cells of Cajal in Sprouty Homolog 4 Deficient Mice
Authors: Peter Vandenberghe
- Hematologie anno 2012 verdiensten van het translationele onderzoek
Authors: Gregor Verhoef, Hélène Schoemans, Timothy Devos, Daan Dierickx, Ann Janssens, Michel Delforge, Johan Maertens, Peter Vandenberghe
Pages: 857 - 861 - Chronic lymphatic leukemia: Not just Rai-Binet and chlorambucil
Authors: Ann Janssens, Gregor Verhoef, Johan Maertens, Peter Vandenberghe
Pages: 904 - 909